Novo Integrated Sciences SG&A Expenses 2012-2024 | NVOS
Novo Integrated Sciences sg&a expenses from 2012 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Novo Integrated Sciences Annual SG&A Expenses
(Millions of US $) |
| 2024 |
$14 |
| 2023 |
$14 |
| 2022 |
$14 |
| 2021 |
$8 |
| 2020 |
$7 |
| 2019 |
$4 |
| 2018 |
$5 |
| 2017 |
$3 |
| 2016 |
$0 |
| 2016 |
$2 |
| 2015 |
$0 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2012 |
$1 |
| 2011 |
$0 |
| 2011 |
$2 |
Novo Integrated Sciences Quarterly SG&A Expenses
(Millions of US $) |
| 2024-08-31 |
$3 |
| 2024-05-31 |
$3 |
| 2024-02-29 |
$3 |
| 2023-11-30 |
$5 |
| 2023-08-31 |
$4 |
| 2023-05-31 |
$3 |
| 2023-02-28 |
$3 |
| 2022-11-30 |
$4 |
| 2022-08-31 |
$5 |
| 2022-05-31 |
$4 |
| 2022-02-28 |
$3 |
| 2021-11-30 |
$3 |
| 2021-08-31 |
$3 |
| 2021-05-31 |
$2 |
| 2021-02-28 |
$2 |
| 2020-11-30 |
$2 |
| 2020-08-31 |
$5 |
| 2020-05-31 |
$1 |
| 2020-02-29 |
$1 |
| 2019-11-30 |
$1 |
| 2019-08-31 |
$1 |
| 2019-05-31 |
$1 |
| 2019-02-28 |
$1 |
| 2018-11-30 |
$1 |
| 2018-08-31 |
$1 |
| 2018-05-31 |
$1 |
| 2018-02-28 |
$2 |
| 2017-11-30 |
$1 |
| 2017-08-31 |
$1 |
| 2017-05-31 |
$1 |
| 2017-03-31 |
|
| 2017-02-28 |
$1 |
| 2016-12-31 |
|
| 2016-11-30 |
$1 |
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-05-31 |
$1 |
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-08-31 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2012-02-29 |
$0 |
| 2011-12-31 |
|
| 2011-11-30 |
$1 |
| 2011-09-30 |
|
| 2011-08-31 |
$0 |
| 2011-06-30 |
|
| 2011-05-31 |
$1 |
| 2011-03-31 |
|
| 2011-02-28 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-OUTP/HM CRE |
$0.000B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
